Clinical Trial Update: Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by Cardiotomography [Phase 3]

View source ↗

Summary

Phase 3 trial updates on dapagliflozin examining effects on coronary calcium and epicardial fat using Cardio tomography.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Type 2 Diabetes Mellitus
• Unstable Angina

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Hilda Elizabeth Macías Cervantes | Conditions: Diabete Type 2, Unstable Angina | Phase 3 | Status: COMPLETED